Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Snibe Co.,Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe) is a global leader in the IVD field, with 30 years o... read more Featured Products: More products

Download Mobile App





SNIBE Showcases Total Lab Automation and Diagnostic Platforms at ADLM 2026

By LabMedica International staff writers
Posted on 30 Jul 2026

SNIBE is presenting its latest in vitro diagnostic and laboratory automation solutions at ADLM 2026 in Anaheim, California, where attendees can visit the company at Booth 3814. More...

The exhibit highlights SNIBE’s focus on integrated diagnostic workflows spanning immunoassay, clinical chemistry, automation, and broader laboratory testing needs.

A central focus of the exhibit is SATLARS mini-T8, the newest member of SNIBE’s Total Laboratory Automation Solutions. Designed for laboratories with limited space, the system integrates pre-analytical and post-analytical sample handling within a compact 2.2 m² footprint. It automates the sample handling and analysis process from loading to storage, while supporting rapid turnaround through compatibility with SNIBE’s high-throughput analyzers.

SNIBE is also showcasing its integrated and high-throughput testing systems, including the Biolumi CX Solution-X10+C10, which combines the MAGLUMI X10 immunoassay analyzer with the Biossays C10 biochemistry analyzer. The system enables immunoassay, biochemical, and ISE testing from one sample loading process, reducing sample transfer steps and helping laboratories improve testing efficiency.

The company’s MAGLUMI X8 chemiluminescence immunoassay system is designed for medium- to large-volume laboratories, offering up to 600 tests per hour in a single module and up to 2,400 tests per hour when four modules are combined. SNIBE’s Biossays C10 biochemistry analyzer further supports high-throughput workflows, with up to 2,000 biochemistry tests per hour, 1,000 ISE tests per hour, whole-blood HbA1c testing, and connectivity with laboratory automation systems.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Three presentations will examine Arima Genomics’ high-throughput Hi-C sequencing technology in salivary gland cancer, triple-negative breast cancer, and aggressive cutaneous T-cell lymphoma (Photo courtesy of Arima Genomics)

New Research Examines Hi-C Sequencing Across Solid Tumors and Lymphoma

Arima Genomics (Carlsbad, CA, USA) will present new research highlighting the expanding clinical applications of its Aventa FusionPlus and Aventa Lymphoma tests at the Association for Molecular Pathology... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Study design and collection of lower respiratory tract lining fluid (RTLF) using the PExA instrument. (Aguilera K, Hober A, Greilert Norin N, et al. eBioMedicine, 2026. doi:10.1016/j.ebiom.2026.106538)

Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways

Respiratory viruses such as influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) require immune protection across the airway mucosa. Antibodies in the respiratory tract lining are important... Read more

Microbiology

view channel
Image: The multiplex molecular panels assess 22 and 11 targets, respectively, spanning bacteria, viruses, and parasites from a single stool sample, with results available in approximately one hour (Photo courtesy of bioMérieux)

Molecular Panels Gain FDA Clearance for One-Hour Gastrointestinal Pathogen Testing

Acute infectious gastroenteritis, caused by viral, bacterial, and parasitic pathogens, remains a significant global health concern that inflames the gastrointestinal tract. Symptoms such as diarrhea, vomiting,... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.